Veru Inc
NASDAQ:VERU

Watchlist Manager
Veru Inc Logo
Veru Inc
NASDAQ:VERU
Watchlist
Price: 2.6 USD -2.99% Market Closed
Market Cap: $38.1m

Operating Margin

0%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Operating
Margin
US
Veru Inc
NASDAQ:VERU
38.1m USD
Loading...
FR
L'Oreal SA
PAR:OR
206.8B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.6B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.6B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.7B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
897.6B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Veru Inc
Glance View

Market Cap
38.1m USD
Industry
Consumer products

Veru, Inc. is an oncology biopharmaceutical company, which engages in developing novel medicines for the management of prostate cancer and breast cancer. The company is headquartered in Miami, Florida and currently employs 252 full-time employees. The firm is focused on developing medicines for the management of breast and prostate cancers. The firm's FC2 segment consists of its commercial product, FC2. The Pharmaceuticals segment includes activities related to multiple drug products under clinical development and ENTADFI, a treatment for benign prostatic hyperplasia. The company has a commercial Sexual Health Division, which includes two products, such as ENTADFI, a treatment for benign prostatic hyperplasia (BPH), and the FC2 Female Condom (Internal Condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

VERU Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Back to Top